Interview with Dr. Ali Tinazli at MedTech Insights
Interview “Spinning Around – One Company’s Bid To Diagnostic-ify The Metabolism”
Press and media
Interview with Dr. Ali Tinazli at “The Health 2.0 Conference” in Dubai
Interview with Dr. Ali Tinazli at Health 2.0 Conference
Revolutionizing Healthcare with AI-Driven Diagnostics
MediWord: An Inverview with CEO Dr. Ali Tinazli
Lifespin Announces the Launch of its First Commercial Product in Regulated Healthcare
Lifespin Amino Acid Profiler™
Lifespin partners with the Leipzig Research Center for Civilization Diseases (LIFE) to obtain deep clinical insights for obesity and diabetes
8,000 patient samples to be digitized and studied for metabolic patterns
Lifespin Announces Inaugural Membership in the Industrial Participant Program of the Wyss Diagnostics Accelerator at Harvard University
Wyss Diagnostics Accelerator seeks to fast-track disruptive diagnostic technologies to meet unmet critical needs
Lifespin Granted ISO13485 Certification for Its Proprietary A.I.-based Metabolomics Platform for In Vitro Diagnostics
ISO13485 certification represents a key milestone towards achieving market-readiness of its automated, high-volume testing infrastructure and ability to build affordable and scalable omics-based precision medicine tools
New Tech Could Improve Diagnostic Accuracy of Prostate Cancer Tests
Dr. Ali Tinazli’s article about “New Tech Could Improve Diagnostic Accuracy of Prostate Cancer Tests”
The Crucial Role Of Predictive Analytics In Precision Medicine
Dr. Ali Tinazli’s post at the Forbes magazine about “The Crucial Role Of Predictive Analytics In Precision Medicine”